SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (941)8/29/1998 8:08:00 PM
From: VLAD   of 1016
 
Brad,

What was the initial promise?

I assume you are reffering to the initial study done by Padmy-pockets-bigman. Seems he stopped touting muse after he left the Vivus payroll.

His mentor Golstein is another crook who is now touting MCHM and I'm sure he will turn on them after he is off the payroll.

As I see it, there is nothing left for Vivus management to screw up--they already screwed everything up including the investors and themselves.

The way I see it now, Vivus either gets sold or finds a partner and gradually makes a slow crawl back to the types of profits seen in 1997.

The ED market is large enough to make Vivus very profitable for its small size.

IMO the price may still drop a hair until the mms get back all the shares they can from margin calls then of course the price will run up as the short positions are covered.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext